1-hexadecyl-2-acetyl-glycero-3-phosphocholine and hydroxysafflor yellow a

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with hydroxysafflor yellow a in 1 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (hydroxysafflor yellow a)	Trials (hydroxysafflor yellow a)	Recent Studies (post-2010) (hydroxysafflor yellow a)
9,156	187	552	255	3	206

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, J; Guo, X; Jin, M; Ma, H; Pan, R; Zang, B; Zheng, M	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and hydroxysafflor yellow a

Article	Year
Hydroxysafflor yellow A (HSYA) targets the platelet-activating factor (PAF) receptor and inhibits human bronchial smooth muscle activation induced by PAF. Food & function, 2019, Aug-01, Volume: 10, Issue:8 Topics: Bronchi; Chalcone; Humans; Interleukin-6; Muscle, Smooth; NF-kappa B; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinones; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha	2019

Article

Year

Hydroxysafflor yellow A (HSYA) targets the platelet-activating factor (PAF) receptor and inhibits human bronchial smooth muscle activation induced by PAF.

Food & function, 2019, Aug-01, Volume: 10, Issue:8

Topics: Bronchi; Chalcone; Humans; Interleukin-6; Muscle, Smooth; NF-kappa B; Platelet Activating Factor; Platelet Membrane Glycoproteins; Quinones; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha

2019